<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "JATS-journalpublishing1.dtd" [
]>
<article xml:lang="en" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"
  dtd-version="1.2" article-type="abstract">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">IJPDS</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Population Data Science</journal-title>
        <abbrev-journal-title>IJPDS</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2399-4908</issn>
      <publisher>
        <publisher-name>Swansea University</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.23889/ijpds.v9i5.2743</article-id>
      <article-id pub-id-type="publisher-id">9:5:253</article-id>
      <title-group>
        <article-title>Prevalence of Congenital Anomalies Before and After Implementation of a Novel Wastewater Treatment Technology in Texas: An Augmented Synthetic Control Method Analysis Utilizing Data from a Population-Based Birth Defects Registry</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Schraw</surname>
            <given-names initials="J">Jeremy</given-names>
          </name>
          <xref ref-type="aff" rid="affil-1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rudolph</surname>
            <given-names initials="K">Kara</given-names>
          </name>
          <xref ref-type="aff" rid="affil-2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shumate</surname>
            <given-names initials="C">Charles</given-names>
          </name>
          <xref ref-type="aff" rid="affil-3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gribble</surname>
            <given-names initials="M">Matthew</given-names>
          </name>
          <xref ref-type="aff" rid="affil-4">4</xref>
        </contrib>
      </contrib-group>
      <aff id="affil-1"><label>1</label><institution>Baylor College of Medicine</institution></aff>
      <aff id="affil-2"><label>2</label><institution>Columbia University</institution></aff>
      <aff id="affil-3"><label>3</label><institution>Texas Department of State Health Services</institution></aff>
      <aff id="affil-4"><label>4</label><institution>University of California San Francisco</institution></aff>
      <pub-date date-type="pub" publication-format="electronic">
        <day>18</day>
        <month>09</month>
        <year>2024</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2024</year>
      </pub-date>
      <volume>9</volume>
      <issue>5</issue>
      <elocation-id>2743</elocation-id>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licences/by/4.0/">
          <license-p>This work is licenced under a Creative Commons Attribution 4.0 International License.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://ijpds.org/article/view/2743">This article is available from the IJPDS website at: https://ijpds.org/article/view/2743</self-uri>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Objectives and Approach</title>
      <p>Direct potable reuse (DPR) involves adding purified wastewater that has not passed through an environmental buffer into a water distribution system. This technology may address growing demand for water in many population centers, but there are no studies of health outcomes in populations receiving DPR-treated drinking water. Our objective was to determine whether the prevalence of congenital anomalies increased in the period following introduction of DPR-treated water to certain public water systems in Texas. We obtained data on all cases with congenital anomalies regardless of pregnancy outcome during 2003-2017 from the population-based Texas Birth Defects Registry. Maternal demographic and residential data were obtained and a reference population of all livebirths in Texas was identified by linkage to birth and fetal death records. The augmented synthetic control method was used to model county-level changes in prevalence of congenital anomalies (expressed per 10,000 livebirths) after the adoption of DPR by four Texas counties in mid-2013. County-level data on maternal age, education, ethnicity, and rural-urban status were included as covariates. Results: We observed increased prevalence of all congenital anomalies collectively (average treatment effect in the treated [ATT] = 53.6) and congenital heart disease (ATT = 287.3) during the years 2014-2017. Neural tube defects prevalence was unchanged.</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>We found evidence that the prevalence of congenital anomalies overall and congenital heart disease specifically increased during the years 2014-2017.</p>
    </sec>
    <sec>
      <title>Implications</title>
      <p>Additional research into reproductive and developmental outcomes among people in areas supplied with DPR-treated water is warranted to inform water policy decisions.</p>
    </sec>
  </body>
</article>